UC Davis partners with DEA approved company to conduct cannabis research

Researchers at the University of California, Davis, have partnered with a federally compliant pharmaceutical company to analyze the chemical and biological profiles of cannabis for the benefit of law enforcement, health care providers and scientific professionals. The agreement with Biopharmaceutical Research Company, which is registered with the U.S. Drug Enforcement Administration, is among the first of its kind. Read more →

Previous
Previous

BRC encourages congress to take up cannabis legislation

Next
Next

3-Year anniversary of DEA’s policy change and no action